This inventor holds 71 USPTO granted patents and 13 published patent applications and 5 EPO patents, primarily in Immunotherapy Techniques. Top assignees: Iovance Biotherapeutics, Inc., Immunocellular Therapeutics, Ltd., Lovance Biotherapeutics, Inc.. Active years: 1997-2026.
Location History:
- Lindenhurst, IL (US) (1997)
- Ballwin, MO (US) (2010 - 2019)
- Rancho Santa Margarita, CA (US) (2013 - 2024)
Company Filing History:
53 out of 110 
3 out of 8 
3 out of 4 Years Active: 1997-2026
Areas of Expertise:
Title: **James Bender: Innovator in Immunotherapy**
Introduction
James Bender, based in Rancho Santa Margarita, California, is a prolific inventor with an impressive portfolio of 52 patents. His work in the field of immunotherapy has significantly contributed to advancements in cancer treatment, particularly through innovative methods in the production of tumor-infiltrating lymphocytes (TILs).
Latest Patents
Among his latest patents, Bender has developed processes for the production of tumor infiltrating lymphocytes and their uses in immunotherapy. This invention focuses on providing improved and shortened methods for expanding TILs, resulting in therapeutic populations that enhance efficacy and metabolic health while reducing microbial contamination and costs. These methods represent a notable advancement in therapeutic treatment regimens.
Career Highlights
James Bender has held significant roles in prominent biotechnology companies, including Iovance Biotherapeutics, Inc. and ImmunoCellular Therapeutics, Ltd. His experience in these organizations has enabled him to lead innovative projects and introduce groundbreaking methods in the field of cellular therapy.
Collaborations
Bender has worked alongside esteemed colleagues such as Seth Wardell and Michael T. Lotze. These collaborations have fostered a productive environment that encourages the exchange of ideas, leading to innovative solutions and advancements in the medical field.
Conclusion
With a substantial number of patents and a dedicated career in immunotherapy, James Bender continues to make significant contributions to the field. His innovative approaches to TIL production highlight his commitment to advancing cancer treatment and improving patient outcomes.